Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access

August 21, 2026 updated by: Jeffrey Coote, University of Alabama at Birmingham

Application of Augmented Reality for Point of Care Ultrasound-Guided Procedures

This study will investigate the benefits of augmented reality assistance on ultrasound-guided vascular access. Using the Microsoft HoloLens 2 headset, the investigators will study the benefits of augmented reality technology as a tool for improving the success rate, efficiency, and ease of access for peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient requiring ultrasound-guided vascular access

Exclusion Criteria:

  • Age less than 5 years old
  • Need for urgent vascular access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Arm
Providers will not use augmented reality assistance when performing ultrasound-guided vascular access for this arm of the study
Experimental: AR Arm
Providers will use augmented reality assistance when obtaining ultrasound-guided vascular access
Other: Augmented reality headset use
Use of a Microsoft HoloLens 2 headset with augmented reality assistance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Successful vascular access as indicated by blood return from the blood vessel and advancement of guide wire
Time Frame: Up to 30 minutes
Up to 30 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of needle sticks required for successful vascular access
Time Frame: Up to 30 minutes
Up to 30 minutes
Time required for successful vascular access
Time Frame: Up to 30 minutes
Up to 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2026

Primary Completion (Actual)

July 31, 2026

Study Completion (Actual)

July 31, 2026

Study Registration Dates

First Submitted

September 19, 2025

First Submitted That Met QC Criteria

September 26, 2025

First Posted (Actual)

October 6, 2025

Study Record Updates

Last Update Posted (Actual)

August 24, 2026

Last Update Submitted That Met QC Criteria

August 21, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRB-300014090
  • UAB (Other Identifier: UAB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe